• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性切除术治疗肝细胞癌患者术后早期肝内复发的术前影像学和术后病理学危险因素。

Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.

机构信息

Department of Diagnostic Radiology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Yonsei Med J. 2009 Dec 31;50(6):789-95. doi: 10.3349/ymj.2009.50.6.789. Epub 2009 Dec 18.

DOI:10.3349/ymj.2009.50.6.789
PMID:20046419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2796405/
Abstract

PURPOSE

The risk of hepatocellular carcinoma (HCC) recurrence must be considered ahead of surgery. This study was undertaken to identify pre-operative risk factors for early intrahepatic recurrence of HCC after curative resection in a large-scale.

MATERIALS AND METHODS

We retrospectively reviewed the preoperative three-phase multi-detector CT (MDCT) and laboratory data for 240 HCC patients who underwent curative resection; tumor size, number, gross shape, capsule integrity, distinctiveness of tumor margin, portal vein thrombosis (PVT), alpha-fetoprotein level (AFP), and protein induced by vitamin K absence-II (PIVKA-II) levels were assessed. Surgical pathology was reviewed; tumor differentiation, capsule, necrosis, and micro-vessel invasion were recorded.

RESULTS

HCC recurred in 61 patients within six months (early recurrence group), but not in 179 patients (control group). In univariate analysis, large tumor size (p = 0.018), shape (p = 0.028), poor capsule integrity (p = 0.046), elevated AFP (p = 0.015), and PIVKA-II (p = 0.008) were significant preoperative risk factors. Among the pathologic features, PVT (p = 0.023), Glisson's capsule penetration (p = 0.033), microvascular invasion (p < 0.001), and poor differentiation (p = 0.001) showed statistical significance. In multivariate analysis, only the histopathologic parameters of microvascular invasion and poor differentiation achieved statistical significance.

CONCLUSION

Preoperative CT and laboratory parameters showed limited value, while the presence of microscopic vascular tumor invasion and poorly differentiated HCC correlated with higher risk of early recurrence after curative resection.

摘要

目的

在手术前必须考虑肝细胞癌(HCC)复发的风险。本研究旨在确定在大规模人群中根治性切除术后 HCC 早期肝内复发的术前危险因素。

材料与方法

我们回顾性分析了 240 例接受根治性切除术的 HCC 患者的术前三期多排 CT(MDCT)和实验室数据;评估肿瘤大小、数量、大体形状、包膜完整性、肿瘤边界清晰度、门静脉血栓形成(PVT)、甲胎蛋白(AFP)和维生素 K 缺乏诱导蛋白 II(PIVKA-II)水平。手术病理检查;记录肿瘤分化、包膜、坏死和微血管侵犯。

结果

61 例患者在 6 个月内(早期复发组)出现 HCC 复发,但 179 例患者(对照组)未复发。单因素分析显示,肿瘤较大(p = 0.018)、形状不规则(p = 0.028)、包膜完整性差(p = 0.046)、AFP 升高(p = 0.015)和 PIVKA-II 升高(p = 0.008)是术前显著的危险因素。在病理特征中,PVT(p = 0.023)、Glisson 包膜穿透(p = 0.033)、微血管侵犯(p < 0.001)和低分化(p = 0.001)具有统计学意义。多因素分析显示,只有微血管侵犯和低分化的组织病理学参数具有统计学意义。

结论

术前 CT 和实验室参数的价值有限,而微血管肿瘤侵犯和低分化 HCC 的存在与根治性切除术后早期复发的风险增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/296c/2796405/c4d3c03f4e58/ymj-50-789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/296c/2796405/c4d3c03f4e58/ymj-50-789-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/296c/2796405/c4d3c03f4e58/ymj-50-789-g001.jpg

相似文献

1
Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.根治性切除术治疗肝细胞癌患者术后早期肝内复发的术前影像学和术后病理学危险因素。
Yonsei Med J. 2009 Dec 31;50(6):789-95. doi: 10.3349/ymj.2009.50.6.789. Epub 2009 Dec 18.
2
Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study.维生素 K 缺乏症诱导的凝血酶原与甲胎蛋白在检测可切除肝细胞癌及根治性肝切除术后早期复发中的作用:一项回顾性队列研究。
Int J Surg. 2022 Sep;105:106843. doi: 10.1016/j.ijsu.2022.106843. Epub 2022 Aug 19.
3
Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.肝切除术后早期出现大量复发的II-III期肝细胞癌的临床病理分析
J Gastroenterol Hepatol. 2000 Oct;15(10):1192-8. doi: 10.1046/j.1440-1746.2000.02323.x.
4
Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.经验证的术前计算机断层扫描风险评估用于预测术后肝细胞癌复发。
World J Gastroenterol. 2017 Sep 21;23(35):6467-6473. doi: 10.3748/wjg.v23.i35.6467.
5
Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma.基于增强 CT 影像的影像组学模型用于 AFP 阴性肝细胞癌根治性切除术后早期复发监测。
BMC Cancer. 2024 Jun 7;24(1):700. doi: 10.1186/s12885-024-12436-x.
6
Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.肝癌患者肝切除术后 1 年内因疾病复发或进展导致早期死亡的危险因素分析。
World J Surg Oncol. 2012 Jun 14;10:107. doi: 10.1186/1477-7819-10-107.
7
Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.用于预测肝细胞癌根治性切除术后早期复发的术前血清肝酶标志物。
Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):178-85. doi: 10.1016/s1499-3872(15)60353-8.
8
Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma.肝细胞癌根治性肝切除术后早期复发的危险因素
Tumour Biol. 2017 Oct;39(10):1010428317720863. doi: 10.1177/1010428317720863.
9
Prediction of tumor recurrence by α-fetoprotein model after curative resection for hepatocellular carcinoma.甲胎蛋白模型预测肝癌根治性切除术后肿瘤复发。
Eur J Surg Oncol. 2021 Mar;47(3 Pt B):660-666. doi: 10.1016/j.ejso.2020.10.017. Epub 2020 Oct 15.
10
Early recurring hepatocellular carcinoma after partial hepatic resection: preoperative CT findings.肝部分切除术后早期复发性肝细胞癌:术前CT表现
Korean J Radiol. 2000 Jan-Mar;1(1):38-42. doi: 10.3348/kjr.2000.1.1.38.

引用本文的文献

1
Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study.根治性肝切除术后辅助使用乐伐替尼治疗高危CNLC IIb/IIIa期肝细胞癌:一项前瞻性探索性研究
J Hepatocell Carcinoma. 2025 May 22;12:1043-1056. doi: 10.2147/JHC.S516478. eCollection 2025.
2
Preoperative plasma cell-free DNA chromosomal instability predicts microvascular invasion in hepatocellular carcinoma: a prospective study.术前血浆游离DNA染色体不稳定预测肝细胞癌微血管侵犯:一项前瞻性研究
BMC Cancer. 2025 May 13;25(1):867. doi: 10.1186/s12885-025-14268-9.
3
Gamma-glutamyl transferase-to-lymphocyte ratio as a prognostic marker in patients with hepatocellular carcinoma undergoing hepatectomy.

本文引用的文献

1
Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.肝细胞癌肝切除术后复发:危险因素、治疗及预后
Surgery. 2007 Mar;141(3):330-9. doi: 10.1016/j.surg.2006.06.028. Epub 2006 Nov 1.
2
Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting milan criteria: Rationale for partial hepatectomy as first strategy.符合米兰标准的初始可切除肝细胞癌的预后与复发:以肝部分切除术作为首选策略的理论依据
J Am Coll Surg. 2007 Jan;204(1):1-6. doi: 10.1016/j.jamcollsurg.2006.10.004. Epub 2006 Nov 28.
3
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma.
γ-谷氨酰转移酶与淋巴细胞比值作为接受肝切除术的肝细胞癌患者的预后标志物
World J Gastrointest Surg. 2025 Feb 27;17(2):98578. doi: 10.4240/wjgs.v17.i2.98578.
4
A Clinical Tool to Predict the Microvascular Invasion Risk in Patients with Hepatocellular Carcinoma.一种用于预测肝细胞癌患者微血管侵犯风险的临床工具。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231182526. doi: 10.1177/15330338231182526.
5
Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomy.一种用于预测肝癌根治性肝切除术后早期复发的新型预后列线图的开发。
Ann Transl Med. 2021 Oct;9(20):1541. doi: 10.21037/atm-21-4837.
6
Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.成像序列、特征提取、特征选择和分类器对基于放射组学的磁共振成像预测肝细胞癌微血管侵犯的显著影响。
Quant Imaging Med Surg. 2021 May;11(5):1836-1853. doi: 10.21037/qims-20-218.
7
Microscopic vascular invasion by hepatocellular carcinoma in liver transplant patients.肝移植患者肝细胞癌的微血管侵犯
Clin Pract (Lond). 2020;17(3):1497-1505.
8
Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation.肝移植后肝细胞癌患者预后预测的研究进展。
J Zhejiang Univ Sci B. 2018 Jul;19(7):497-504. doi: 10.1631/jzus.B1700156.
9
A new prognostic model for hepatocellular carcinoma recurrence after curative hepatectomy.一种用于肝细胞癌根治性肝切除术后复发的新预后模型。
Oncol Lett. 2018 Apr;15(4):4411-4422. doi: 10.3892/ol.2018.7821. Epub 2018 Jan 19.
10
VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma.血管内皮生长因子过表达预示肝细胞癌患者预后不良。
Open Med (Wars). 2017 Dec 9;12:430-439. doi: 10.1515/med-2017-0061. eCollection 2017.
肝细胞癌肝切除术后早期多结节复发相关危险因素分析
Am J Surg. 2006 Jul;192(1):29-33. doi: 10.1016/j.amjsurg.2005.11.010.
4
Staging and current treatment of hepatocellular carcinoma.肝细胞癌的分期与当前治疗方法
Radiographics. 2005 Oct;25 Suppl 1:S3-23. doi: 10.1148/rg.25si055507.
5
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma.通过评估血管情况对肝硬化小结节进行特征分析:乏血管性肝细胞癌的问题
Hepatology. 2005 Jul;42(1):27-34. doi: 10.1002/hep.20728.
6
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database.肝切除术治疗大肝癌或多结节肝细胞癌是否合理?多机构数据库的结果
Ann Surg Oncol. 2005 May;12(5):364-73. doi: 10.1245/ASO.2005.06.004. Epub 2005 Mar 31.
7
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.肝切除术后肝细胞癌早期和晚期肝内复发的危险因素。
J Hepatol. 2003 Feb;38(2):200-7. doi: 10.1016/s0168-8278(02)00360-4.
8
Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter.直径大于10厘米的大肝细胞癌患者肝切除的选择标准。
J Am Coll Surg. 2002 May;194(5):592-602. doi: 10.1016/s1072-7515(02)01163-8.
9
Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.直径大于或等于10厘米的肝细胞癌的肝切除术
Hepatogastroenterology. 2002 Mar-Apr;49(44):518-23.
10
Prognostic prediction and treatment strategy in hepatocellular carcinoma.肝细胞癌的预后预测与治疗策略
Hepatology. 2002 Mar;35(3):519-24. doi: 10.1053/jhep.2002.32089.